These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 26632439

  • 1. An Integrated In Silico Method to Discover Novel Rock1 Inhibitors: Multi- Complex-Based Pharmacophore, Molecular Dynamics Simulation and Hybrid Protocol Virtual Screening.
    Chen H, Li S, Hu Y, Chen G, Jiang Q, Tong R, Zang Z, Cai L.
    Comb Chem High Throughput Screen; 2016; 19(1):36-50. PubMed ID: 26632439
    [Abstract] [Full Text] [Related]

  • 2. Development and evaluation of an integrated virtual screening strategy by combining molecular docking and pharmacophore searching based on multiple protein structures.
    Tian S, Sun H, Li Y, Pan P, Li D, Hou T.
    J Chem Inf Model; 2013 Oct 28; 53(10):2743-56. PubMed ID: 24010823
    [Abstract] [Full Text] [Related]

  • 3. Discovery of Novel ROCK1 Inhibitors via Integrated Virtual Screening Strategy and Bioassays.
    Shen M, Tian S, Pan P, Sun H, Li D, Li Y, Zhou H, Li C, Lee SM, Hou T.
    Sci Rep; 2015 Nov 16; 5():16749. PubMed ID: 26568382
    [Abstract] [Full Text] [Related]

  • 4. In silico screening-based discovery of benzamide derivatives as inhibitors of Rho-associated kinase-1 (ROCK1).
    Xu QX, Guo L, Li Y, Wang ZW, Hu P, Yang GM, Pan Y.
    J Biomol Struct Dyn; 2024 Sep 16; 42(14):7467-7484. PubMed ID: 37668086
    [Abstract] [Full Text] [Related]

  • 5. Identification of novel inhibitors of DDR1 against idiopathic pulmonary fibrosis by integrative transcriptome meta-analysis, computational and experimental screening.
    Chen C, Deng J, Yu X, Wu F, Men K, Yang Q, Zhu Y, Liu X, Jiang Q.
    Mol Biosyst; 2016 Apr 26; 12(5):1540-51. PubMed ID: 26956955
    [Abstract] [Full Text] [Related]

  • 6. Discovery of novel focal adhesion kinase inhibitors using a hybrid protocol of virtual screening approach based on multicomplex-based pharmacophore and molecular docking.
    Wu F, Xu T, He G, Ouyang L, Han B, Peng C, Song X, Xiang M.
    Int J Mol Sci; 2012 Nov 23; 13(12):15668-78. PubMed ID: 23443087
    [Abstract] [Full Text] [Related]

  • 7. Discovery and optimization of triazine derivatives as ROCK1 inhibitors: molecular docking, molecular dynamics simulations and free energy calculations.
    Shen M, Zhou S, Li Y, Pan P, Zhang L, Hou T.
    Mol Biosyst; 2013 Mar 23; 9(3):361-74. PubMed ID: 23340525
    [Abstract] [Full Text] [Related]

  • 8. Discovery of Rho-kinase inhibitors by docking-based virtual screening.
    Shen M, Yu H, Li Y, Li P, Pan P, Zhou S, Zhang L, Li S, Lee SM, Hou T.
    Mol Biosyst; 2013 Jun 23; 9(6):1511-21. PubMed ID: 23549429
    [Abstract] [Full Text] [Related]

  • 9. Novel hybrid virtual screening protocol based on molecular docking and structure-based pharmacophore for discovery of methionyl-tRNA synthetase inhibitors as antibacterial agents.
    Liu C, He G, Jiang Q, Han B, Peng C.
    Int J Mol Sci; 2013 Jul 09; 14(7):14225-39. PubMed ID: 23839093
    [Abstract] [Full Text] [Related]

  • 10. Identification of novel CDK 9 inhibitors based on virtual screening, molecular dynamics simulation, and biological evaluation.
    Wu M, Han J, Liu Z, Zhang Y, Huang C, Li J, Li Z.
    Life Sci; 2020 Oct 01; 258():118228. PubMed ID: 32781071
    [Abstract] [Full Text] [Related]

  • 11. Discovery of a novel ROCK2 inhibitor with anti-migration effects via docking and high-content drug screening.
    Chong CM, Kou MT, Pan P, Zhou H, Ai N, Li C, Zhong HJ, Leung CH, Hou T, Lee SM.
    Mol Biosyst; 2016 Aug 16; 12(9):2713-21. PubMed ID: 27354305
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease.
    Iqbal S, Anantha Krishnan D, Gunasekaran K.
    J Biomol Struct Dyn; 2018 Nov 16; 36(15):4029-4044. PubMed ID: 29182053
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Discovery of novel Bruton's tyrosine kinase inhibitors using a hybrid protocol of virtual screening approaches based on SVM model, pharmacophore and molecular docking.
    Wan HL, Wang ZR, Li LL, Cheng C, Ji P, Liu JJ, Zhang H, Zou J, Yang SY.
    Chem Biol Drug Des; 2012 Sep 16; 80(3):366-73. PubMed ID: 22594639
    [Abstract] [Full Text] [Related]

  • 16. Identification and evaluation of bioactive natural products as potential inhibitors of human microtubule affinity-regulating kinase 4 (MARK4).
    Mohammad T, Khan FI, Lobb KA, Islam A, Ahmad F, Hassan MI.
    J Biomol Struct Dyn; 2019 Apr 16; 37(7):1813-1829. PubMed ID: 29683402
    [Abstract] [Full Text] [Related]

  • 17. In silico exploration of c-KIT inhibitors by pharmaco-informatics methodology: pharmacophore modeling, 3D QSAR, docking studies, and virtual screening.
    Chaudhari P, Bari S.
    Mol Divers; 2016 Feb 16; 20(1):41-53. PubMed ID: 26416560
    [Abstract] [Full Text] [Related]

  • 18. Virtual Screening Using Pharmacophore Models Retrieved from Molecular Dynamic Simulations.
    Polishchuk P, Kutlushina A, Bashirova D, Mokshyna O, Madzhidov T.
    Int J Mol Sci; 2019 Nov 20; 20(23):. PubMed ID: 31757043
    [Abstract] [Full Text] [Related]

  • 19. Integration of virtual screening with high-throughput screening for the identification of novel Rho-kinase I inhibitors.
    Gong LL, Fang LH, Peng JH, Liu AL, Du GH.
    J Biotechnol; 2010 Feb 01; 145(3):295-303. PubMed ID: 19963024
    [Abstract] [Full Text] [Related]

  • 20. Identification of CK2 inhibitors with new scaffolds by a hybrid virtual screening approach based on Bayesian model; pharmacophore hypothesis and molecular docking.
    Di-wu L, Li LL, Wang WJ, Xie HZ, Yang J, Zhang CH, Huang Q, Zhong L, Feng S, Yang SY.
    J Mol Graph Model; 2012 Jun 01; 36():42-7. PubMed ID: 22516037
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.